POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the US Food and Drug Administration approval of VIMOVO™ delayed-release tablets on April 30 th .
40244
POZEN announces receipt of $20 million milestone payment from AstraZeneca
140675
Vapotherm secures $20.5 million in new equity financing
108888
Pain Therapeutics receives $5,000,000 payment
74104
Eastman completes acquisition of Solutia
91515
Pfizer gets the approval
157439
Opsona Therapeutics raises €18 million
100390
Teva Pharmaceutical launches generic Yaz
143014
StatoilHydro granted consent to use Volve
126233
Astex achieves milestones in drug discovery collaboration
92671
FDA approves Onglyza for Type 2 diabetes
135657
Pharmaceutical product development raises dividend 20 percent
174721
NovaDel Pharma Inc. receives $500,000 milestone payment
129407
E-Therapeutics granted US patent for key process
130449
SpinVox gains rapid market acceptance
26140
ClearKone® prescribed to more than 16,000 patients in 32 countries
67539
YM BioSciences reports nimotuzumab approved for marketing in Mexico
119899
AVI Biopharma secures increased funding of approximately $4.0 million